Valuation : FDC Limited

Market Cap 52.29B 547M 471M 442M 404M 760M 763M 5.24B 2.05B 26.4B 2.05B 2.01B 87.53B P/E 2024
22.8x
P/E 2025 24.1x
Enterprise Value 47.15B 493M 425M 399M 364M 685M 688M 4.73B 1.84B 23.8B 1.85B 1.81B 78.91B EV / Sales 2024
3.32x
EV / Sales 2025 2.8x
Free-Float
5.15%
Yield 2024 *
-
Yield 2025 1.27%
1 day-0.47%
1 week-2.44%
Current month-16.58%
1 month-18.02%
3 months-19.99%
6 months-4.15%
Current year-19.18%
1 week 340.8
Extreme 340.8
357.5
1 month 340
Extreme 340
425
Current year 314.75
Extreme 314.75
442
1 year 314.75
Extreme 314.75
528.3
3 years 314.75
Extreme 314.75
659
5 years 229.15
Extreme 229.15
659
10 years 148.2
Extreme 148.2
659
Manager TitleAgeSince
Chief Executive Officer 90 18/11/2009
Chief Executive Officer 63 30/09/1993
Director of Finance/CFO - 23/10/2025
Director TitleAgeSince
Director/Board Member 48 31/12/2001
Director/Board Member 63 30/09/1993
Chairman 90 31/03/2026
Change 5-day change 1-year change 3-year change Capi.($)
-0.47%-2.44%-25.76%-10.37% 586M
-0.13%-6.44%+60.47%+112.05% 1,048B
+0.85%-0.81%+52.77%+63.15% 640B
-1.03%-3.58%+22.87%+73.29% 456B
-1.46%-4.50%+37.43%+38.41% 362B
-0.72%-2.89%+21.86%+36.79% 295B
-1.19%-2.21%+1.35%+12.29% 255B
-1.05%-1.57%+51.40%+68.55% 236B
+0.08%-1.78%-17.64%-54.29% 204B
-2.14%-0.30%+29.42%+89.10% 185B
Average -0.74%-1.18%+23.42%+42.90% 368.22B
Weighted average by Cap. -0.49%-2.50%+38.55%+65.40%

Financials

2024 2025
Net sales 19.43B 203M 175M 164M 150M 282M 283M 1.95B 760M 9.81B 763M 747M 32.52B 21.08B 221M 190M 178M 163M 306M 307M 2.11B 825M 10.64B 828M 810M 35.29B
Net income 3.05B 31.94M 27.52M 25.8M 23.55M 44.37M 44.51M 306M 119M 1.54B 120M 117M 5.11B 2.67B 27.91M 24.05M 22.55M 20.59M 38.78M 38.91M 268M 104M 1.35B 105M 103M 4.47B
Net Debt -4.55B -47.6M -41.02M -38.46M -35.11M -66.13M -66.34M -456M -178M -2.3B -179M -175M -7.61B -5.15B -53.88M -46.43M -43.53M -39.74M -74.86M -75.1M -516M -202M -2.6B -202M -198M -8.62B
Logo FDC Limited
FDC Limited is an India-based company, which is principally engaged in the business of manufacturing and trading of pharmaceutical products. The Company is specialized in manufacturing Oral Rehydration Solutions (ORS), energy drinks, antibiotics and ophthalmic therapies. Its products include Albuterol Sulfate, Bromhexine Hydrochloride, Cinnarizine, Flunarizine Dihydrochloride, Flurbiprofen Sodium, Miconazole Nitrate, Timolol Maleate, Amoxycillin + Clavulanic Acid, Rupatadine Fumarate, Salbutamol Sulphate, Kaolin Light/ Pectin, among others. The Company’s product offerings cover an extensive range of categories, including anti-infectives, gastrointestinal treatments, ophthalmic, vitamins, minerals, dietary supplements, cardiovascular solutions, anti-diabetics, respiratory care, gynecology, dermatology and analgesics. Its various brands include Zifi, Electral, Enerzal, Vitcofol, Pyrimon, Zocon, Zoxan, Zathrin, Zipod, Zefu, Cotaryl and Mycoderm.
Employees
6,857
Date Price Change Volume
28/08/26 ₹342.10 -0.47% 5,325
27/08/26 ₹343.70 -1.38% 3,114
26/08/26 ₹348.50 +1.31% 6,222
25/08/26 ₹344.00 -0.30% 3,388
24/08/26 ₹345.05 -0.90% 5,392
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
B